🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Please register now. There are many short and flash talks that will be selected.

Exciting new findings from our Kadoch Lab Dana-Farber Harvard Medical School HHMI regarding the role for #chromatin remodelers in viral infection! This was a terrific collaboration with the Craig Wilen Yale School of Medicine ! Congrats, Ajinkya Patil and Jin Wei on this beautiful work!

Happy to see our work on #Tcells #CART out today in Molecular Cell! Great collaboration with my good friend and colleague, Iannis Aifantis as we worked out the role for #BAFcomplexes in mediating T cell #exhaustion. cell.com/molecular-cell…

The CIHR-ICR | IC-IRSC is sponsoring Canada’s participation on a new joint transnational call with the EU, the ERA-NET TRANSCAN-3 – which is focused on translational research on cancer epigenomics transcan.eu/news-and-resou… Call Launch: May 9th 2023 Pre-proposal deadline: July 2023

Online Now: Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer dlvr.it/StCZzv

"This study has revealed a new vulnerability of a subset of lung #adenocarcinomas that have become resistant to standard-of-care targeted therapies,” said Dr. Katerina Politi @politikaterina. yalecancercenter.org/news-article/r… Smilow Cancer Hospital Yale School of Medicine Yale New Haven Hosp Yale Pathology Cancer Cell

Today Cell, Cancer Cell and Cell Reports Medicine are pleased to publish the 1st wave of Pan-#Cancer multiomics papers looking at over 1000 patients across 10 #tumor types from National Cancer Institute Clinical Proteomic Tumor Analysis Consortium #CPTAC (1/n) Cancer Cell Cell Reports Medicine #openaccess

🏆🌟 Félicitations aux 5 récipiendaires de notre Bourse pour la relève scientifique 2023 ! 🔬 👩‍🔬👨‍🔬 ✨Ensemble, investissons dans l'avenir de la recherche pour déjouer le cancer ! 💪 👉Pour en savoir plus : loom.ly/45s4PG0 #SocietedeRecherchesurleCancer #RechercheCancer

I am honoured to have received the 2023 Next Generation of Scientists Award from the #CancerResearchSociety to support my transition to an independent academic position! #postdoc #CanadianCancerResearch

Featured in The Scientist, research in lung cancer cell lines co-led by Dana-Farber's Cigall Kadoch, PhD ( Cigall Kadoch), found that chromatin remodeling underlies one type of osimertinib resistance. ms.spr.ly/60179YXNh

New study by Cigall Kadoch, PhD (Cigall Kadoch) Dana-Farber reveals the sequence-specific contributions of intrinsically disordered proteins known as IDRs, which are implicated in cancer. CELL ms.spr.ly/60109oP6O

A study in Cancer Cell, led by Matthew Oser, MD, PhD (OserLab) & Cigall Kadoch, PhD (Cigall Kadoch) at @danafarber identify SWI/SNF inhibitors as a potential targeted treatment for POU2F3-positive small cell lung cancer, accounting for 12% of cases. Study ▶️ ms.spr.ly/6016lRrkI